To assess the ability of common genetic variants in aggregate to predict drug-induced QT prolongation in healthy subjects. We will recruit 80 healthy volunteers drawn from the top and bottom quintiles of a QT genotype score for assessment of QT response to moxifloxacin compared to placebo at the Massachusetts General Hospital (MGH).